#1 Clinical Trials Search in Europe

Paracetamol

This article examines the use of paracetamol (also known as acetaminophen) in various clinical trials. These studies investigate the drug’s safety, effectiveness for pain relief, and comparisons with other medications. The trials cover different aspects of paracetamol use, from bioequivalence studies to its application in specific medical procedures.

Table of Contents

What is Paracetamol?

Paracetamol, also known as acetaminophen, is a widely used medication for pain relief and fever reduction[1]. It’s available in various forms, including tablets, capsules, and liquid formulations. Some common brand names for paracetamol include Panadol and Tylenol[2].

Uses of Paracetamol

Paracetamol is used to treat a variety of conditions, including:

  • Pain relief: It’s effective for mild to moderate pain, such as headaches, toothaches, and pain associated with osteoarthritis (a type of joint disease)[1].
  • Fever reduction: Paracetamol can help lower body temperature in cases of fever[1].
  • Chronic pain management: It’s used in the treatment of long-term pain conditions, often in combination with other medications[3].
  • Post-operative pain: Paracetamol is commonly used to manage pain after surgical procedures[4].

Dosage and Administration

The typical dosage of paracetamol for adults is 500-1000 mg every 4-6 hours, with a maximum daily dose of 4000 mg (4 grams)[5]. However, it’s crucial to follow the dosage instructions provided by your healthcare provider or on the product label. Paracetamol can be taken orally as tablets, capsules, or liquid, and in some cases, it may be administered intravenously (through a vein) in hospital settings[4].

Side Effects and Safety

While paracetamol is generally considered safe when used as directed, it can have side effects and potential risks:

  • Liver toxicity: Taking too much paracetamol can cause severe liver damage. It’s crucial not to exceed the recommended daily dose[5].
  • Blood pressure effects: Some studies are investigating whether certain formulations of paracetamol (like effervescent tablets) might affect blood pressure in people with hypertension (high blood pressure)[1].
  • Allergic reactions: Although rare, some people may experience allergic reactions to paracetamol[6].

It’s important to inform your healthcare provider about all medications you’re taking, as paracetamol can interact with other drugs[3].

Comparisons with Other Medications

Paracetamol is often compared to or combined with other pain-relieving medications:

  • NSAIDs: Unlike non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, paracetamol doesn’t have significant anti-inflammatory effects but may have fewer gastrointestinal side effects[6].
  • Opioids: Paracetamol is sometimes combined with mild opioids like codeine for stronger pain relief[3].
  • Ketoprofen: Some studies compare the effectiveness of paracetamol to other pain relievers like ketoprofen for specific conditions[4].

Ongoing Research

Researchers continue to study paracetamol to better understand its effects and improve its use:

  • Safety at higher doses: Studies are investigating the safety of paracetamol at doses higher than the current recommended maximum, particularly with formulations designed to be safer for the liver[5].
  • Effects on blood pressure: Research is ongoing to determine if certain formulations of paracetamol might affect blood pressure in people with hypertension[1].
  • Use in specific conditions: Studies are exploring the effectiveness of paracetamol for various conditions, such as catheter-related bladder discomfort[7].
  • Combination therapies: Researchers are investigating how paracetamol works in combination with other pain-relieving medications[3].
Aspect Details
Bioequivalence Studies Compare generic (Fortolin Tab 500mg) and brand-name (Panadol Caplet 500mg) paracetamol
High-Dose Safety Investigate SafeTynadol® at doses from 4,000 mg to 12,000 mg daily
Pain Relief Comparison Compare paracetamol to other analgesics for fractional curettage pain
Post-Operative Use Evaluate IV paracetamol for pain after appendectomy
Key Measurements Cmax, AUC, Tmax, t1/2, liver function tests, pain scores
Safety Monitoring Focus on liver function and potential hepatotoxicity

FAQ

  • What is the purpose of bioequivalence studies for paracetamol? Bioequivalence studies, like the one comparing Fortolin Tab 500mg and Panadol Caplet 500mg, aim to compare the bioavailability of generic and brand-name paracetamol products. This helps determine if the generic version can be safely substituted for the brand-name drug.
  • How is paracetamol being tested for safety at higher doses? A study is investigating the safety of SafeTynadol®, a paracetamol formulation, at doses ranging from 4,000 mg to 12,000 mg per day. This research aims to understand the drug's effects on liver function and potential hepatotoxicity at higher doses.
  • How does paracetamol compare to other pain relievers in medical procedures? A clinical trial is comparing the effectiveness of paracetamol to other pain relievers like dexketoprofen trometamol, lidocaine spray, pethidine, and diclofenac sodium for pain relief during fractional curettage, a gynecological procedure.
  • Is intravenous paracetamol effective for post-operative pain management? A study is evaluating the impact of intravenous acetaminophen (paracetamol) on post-operative pain after laparoscopic appendectomy for perforated appendicitis. It aims to determine if IV paracetamol can reduce the time needed for patient-controlled analgesia.
  • What are some common measurements used in paracetamol clinical trials? Clinical trials often measure peak drug concentration (Cmax), area under the drug plasma concentration-time curve (AUC), time to maximum concentration (Tmax), and terminal elimination half-life (t1/2) of paracetamol. Some studies also monitor liver function tests and pain scores.

Ongoing Clinical Trials on Paracetamol

  • Study on the Safety and Effects of THOR-707 and Drug Combination in Adults with Advanced or Metastatic Cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study of Epcoritamab for Patients with Relapsed, Progressive, or Refractory B-Cell Lymphoma

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark Finland France Germany Italy The Netherlands +3

  • Study Comparing Epcoritamab with Chemotherapy for Patients with Relapsed or Refractory B-cell Lymphoma

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Austria Belgium Denmark Finland France Germany +7

  • Study on the Effects of a Higher Dose of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis

    Not recruiting

    1 1 1
    Investigated drugs:
    Belgium Bulgaria Denmark France Germany Greece +5

  • Study on the Effects of a Higher Dose of Ocrelizumab for Adults with Relapsing Multiple Sclerosis

    Not recruiting

    1 1 1
    Investigated drugs:
    Belgium Denmark France Germany Greece Hungary +4

  • Study of Elranatamab, Dexamethasone, and Diphenhydramine Hydrochloride for Patients with High-Risk Smoldering Multiple Myeloma

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Finland France Greece Italy The Netherlands Norway

  • Study of Isatuximab, Lenalidomide, and Dexamethasone for Patients with High-Risk Smoldering Multiple Myeloma

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Denmark France Germany Greece Hungary +5

  • Study on the Safety and Effects of AZD7789 for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma

    Not recruiting

    1 1 1
    Investigated drugs:
    Denmark France Italy Spain

  • Study of SAR443579 Infusion for Adults and Children with Relapsed or Refractory Acute Myeloid Leukemia, B-Cell Acute Lymphoblastic Leukemia, HR-MDS, or BPDCN

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France The Netherlands

  • Study on the Effectiveness and Safety of Ocrelizumab for Patients with Progressive Multiple Sclerosis

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Denmark France Germany Italy The Netherlands +1

Glossary

  • Bioequivalence: A comparison of the biological equivalence of two products with the same active ingredient, usually a generic drug and a brand-name drug, to see if they have the same effect in the body.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Hepatotoxicity: Liver damage caused by exposure to drugs or other substances.
  • ALT (Alanine Aminotransferase): An enzyme found mainly in the liver; high levels in the blood can indicate liver damage.
  • Fractional Curettage: A gynecological procedure that involves scraping and collecting tissue from the inside of the uterus.
  • Patient-Controlled Analgesia (PCA): A method of pain control that allows patients to self-administer small doses of pain medication, usually through an intravenous line.
  • Bioavailability: The proportion of a drug that enters the circulation when introduced into the body and is able to have an active effect.
  • Cmax: The maximum concentration of a drug in the blood after it has been administered.
  • AUC (Area Under the Curve): A measure of the total exposure to a drug over time, used in pharmacokinetic studies.
  • Tmax: The time it takes for a drug to reach its maximum concentration in the blood.

References

  1. https://clinicaltrials.gov/study/NCT02514538
  2. https://clinicaltrials.gov/study/NCT03562780
  3. https://clinicaltrials.gov/study/NCT02032927
  4. https://clinicaltrials.gov/study/NCT02439034
  5. https://clinicaltrials.gov/study/NCT05563961
  6. https://clinicaltrials.gov/study/NCT03781544
  7. https://clinicaltrials.gov/study/NCT01652183